1-3 of 3
Andrea Bontadini, MD
Close
Sort by
Journal Articles

Erucylphosphohomocholine, the First Intravenously Applicable Alkylphosphocholine, Induces Cell Cycle Arrest, Apoptosis, and Synergizes with Chemotherapeutic Drugs in Acute Myelogenous Leukemia Cells-a Novel Therapeutic Approach for Leukemia.

Veronica Papa, BS, PierLuigi Tazzari, MD, Francesca Chiarini, BS, Francesca Ricci, BS, Giovanni Martinelli, MD, Andrea Bontadini, MD, James McCubrey, PhD, Lars H Lindner, MD, Hansjoerg Eibl, PhD, Alberto M. Martelli, MD
Journal: Blood
Blood (2008) 112 (11): 1330.
https://doi.org/10.1182/blood.V112.11.1330.1330
Published: 2008
Journal Articles

Synergistic Proapoptotic Activity of Recombinant TRAIL Plus the Akt Inhibitor Perifosine in Acute Myelogenous Leukemia Cells-a Novel Therapeutic Approach for Leukemia Displaying Elevated Akt Signaling.

PierLuigi Tazzari, MD, Veronica Papa, BS, Francesca Ricci, BS, Francesca Chiarini, BS, Camilla Evangelisti, PhD, Giovanni Martinelli, MD, Andrea Bontadini, MD, James McCubrey, PhD, Alberto M. Martelli, MD
Journal: Blood
Blood (2008) 112 (11): 957.
https://doi.org/10.1182/blood.V112.11.957.957
Published: 2008
Journal Articles

Phase I-II Trial of Adoptive Immunotherapy with Haploidentical KIR Ligand-Mismatched Natural Killer Cells in High Risk Acute Myeloblastic Leukemia Patients.

Antonio Curti, MD, Loredana Ruggeri, BS, Alessandra D’Addio, MD, Elena Urbani, BS, Andrea Bontadini, MD, Fiorenza Fruet, BS, Valeria Giudice, MD, Elisa Dan, BS, Maria Rosa Motta, BS, Simona Rizzi, BS, Stefania Paolini, MD, Gabriele Gugliotta, MD, Roberto Conte, MD, Giovanni Martinelli, MD, Andrea Velardi, MD, Michele Baccarani, MD, Roberto M. Lemoli, MD
Journal: Blood
Blood (2007) 110 (11): 2857.
https://doi.org/10.1182/blood.V110.11.2857.2857
Published: 2007